Picoline based fluorescence ‘turn-on’ chemosensor for zinc(II) ion recognition, cell imaging and cytotoxicity study: Synthesis, crystal structure, spectroscopy and DFT

A picoline based ‘turn-on’ chemosensor (L) and it’s zinc(II) complex, Zn(L)2 (1) have been synthesized and structurally characterized. The detection limit (0.36 µM) and association constant (log Kapp = 13.25) are evaluated by the fluorescence experiment. The probe shows reversibility in addition of...

Full description

Saved in:
Bibliographic Details
Published inPolyhedron Vol. 192; pp. 114815 - 114827
Main Authors Jana, Abhimanyu, Aher, Abhishek, Brandao, Paula, Ali, Syed Samim, Samanta, Sandip Kumar, Mondal, Gopinath, Bera, Pradip, Santra, Ananyakumari, Manna, Sunil Kumar, Mahapatra, Ajit Kumar, Bera, Pulakesh
Format Journal Article
LanguageEnglish
Published OXFORD Elsevier Ltd 01.12.2020
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A picoline based ‘turn-on’ chemosensor (L) and it’s zinc(II) complex, Zn(L)2 (1) have been synthesized and structurally characterized. The detection limit (0.36 µM) and association constant (log Kapp = 13.25) are evaluated by the fluorescence experiment. The probe shows reversibility in addition of dihydrogen phosphate (H2PO4−) ion to the 1. The probe has sufficient cell permeability and intracellular Zn(II) imaging property. Both L and 1 are innocuous against PBMC (peripheral blood mononuclear cells) but effective antitumor agents against U-937 cancer cells. [Display omitted] •Synthesis and structure of a highly selective and sensitive picoline based small molecule (Mol. Wt. 254).•A ‘turn on’ fluorescent probe with Zn(II) in HEPES buffer.•Excellent bleaching of fluorescence in H2PO4− to the Zn-complex.•Ligand has sufficient cell permeability and intracellular Zn(II) sensing property.•Compounds are innocuous against PBMC but effective antiproliferative against U-937 cancer cells. A new picoline based ligand, namely 2-hydroxy-5-methyl-3-[{(6-methylpyridin-2-yl)imino}methyl]benzaldehyde (L) and it’s zinc(II) complex, Zn(L)2 (1) have been synthesized and structurally characterized. The ligand (L) selectively interacts with Zn2+ ion in presence of series of cations in CH3CN-H2O (v/v 1:1) in 1 mM HEPES buffer (pH 7.2). The fluorescence intensity of L is significantly enhanced, and it is increased to 52 times on coordination with Zn(II) ion. The fluorescence intensity value of the L does not show any significant change in the pH range 5 to 9, while the extent of emission phenomenon with Zn(II) ions is observed in the said pH range. The detection limit (0.36 µM) and association constant (log Kapp = 13.25) are evaluated by the fluorescence emission experiment. The probe shows reversibility in addition of dihydrogen phosphate (H2PO4−) ion to the 1. Additionally, the ‘turn-on’ fluorescence probe has sufficient cell permeability and intracellular Zn(II) sensing property as envisaged from the microscopic imaging in HEK293T cells. Both L and ZnL2 (1) are innocuous against PBMC (peripheral blood mononuclear cells) but effective antitumor agents against U-937 cancer cells.
ISSN:0277-5387
DOI:10.1016/j.poly.2020.114815